<DOC>
	<DOCNO>NCT00220233</DOCNO>
	<brief_summary>This study test efficacy safety combination olmesartan amlodipine hypertensive patient whose blood pressure adequately control amlodipine alone</brief_summary>
	<brief_title>Olmesartan Add-on Amlodipine Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Without antihypertensive pretreatment mean seat BP great 160/100 mmHg Pretreatment amlodipine 5 10 mg : mean seat BP great equal 140/90 mmHg Secondary hypertension Any serious disorder may limit ability evaluate efficacy safety test drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>